Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPG Block for Headache in Aneurysmal SAH
NCT04331938Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2020
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of bupivacaine and dexamethasone in Headache, sponsored by Mayo Clinic. Primary endpoint: Reduction in patient reported pain using a standard numeric rating scale at 1 day. Started Nov 2020; status: completed.
02
Drugs
bupivacainedexamethasone
03
Conditions
Headache
Beyond the preview
Go deeper on NCT04331938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04331938.